Skip to main content
. 2018 Oct 13;8(2):162–168. doi: 10.1002/sctm.18-0103

Figure 1.

Figure 1

(A): schematic representation of the murine hind‐ischemia model and cell therapy strategy adopted. (B): high‐resolution laser Doppler images taken demonstration complete ischemia postsurgery (day 0) and improvement in reperfusion over time. (C): quantification of the limb reperfusion as measured by the laser Doppler (*p < .05, **p < .01). Red line, ECFC + MSC + vehicle; green line, ECFC + MSC + C/S. (D): quantification of fee lost in mice treated with or without C/S (**p < .01). (E): assessment of T‐cell infiltrate with or without C/S treatment (**p < .01; ***p < .001). All error bars represented as standard deviation. Abbreviations: C/S, cyclosporine; ECFC, endothelial colony forming cells; HLI, hind limb ischemia; MSC, mesenchymal stem cells.